Search results
Earnings call: Almirall targets leadership in medical dermatology with Q1 growth By Investing.com
Investing.com· 6 hours agoAlmirall, the pharmaceutical company specializing in medical dermatology, outlined a solid start to...
IPC Develops Consensus on Generalized Pustular Psoriasis
Medscape· 6 days agoThe IPC's definition and diagnostic criteria for GPP minimized the complexity of clinical...
LEO Pharma reports positive data from Phase III plaque psoriasis trial
Clinical Trials Arena via Yahoo Finance· 6 days agoA total of 604 patients across 39 sites in China participated in the study. The primary goal of the...
AnaptysBio reports positive phase 3 GPP trial results By Investing.com
Investing.com· 4 days agoAnaptysBio, Inc. (NASDAQ:ANAB), a clinical-stagebiotechnology company, announced positive results...
New treatment could reverse hair loss caused by autoimmune skin disease alopecia areata
Medical Xpress· 5 days agoThe team has developed a microneedle patch that can be painlessly applied to the scalp and releases...
Protagonist Therapeutics Inc (PTGX) Surpasses Q1 Revenue Estimates with Strategic Collaborations
GuruFocus.com via Yahoo Finance· 6 days agoThis positions JNJ-2113, a novel oral IL-23 receptor antagonist, as a potential leader in psoriasis ...
Teva Pharm to launch Humira biosimilar as Q1 profit misses estimates
Reuters· 5 days ago, opens new tab blockbuster arthritis drug Humira in the coming weeks after it posted mixed results in the first three months of 2024. In the wake of February's U.S. Food and Drug Administration ...
Benefits of Salicylic Acid For Skin
Health via Yahoo News· 3 days agoProducts containing salicylic acid are used to treat many different skin conditions, such as: Acne Warts Psoriasis Seborrhoeic dermatitis (dandruff)...
Bryhali dosage: Form, strength, how to use, and more
Medical News Today· 4 days agoBryhali (halobetasol) is a brand-name drug prescribed to treat plaque psoriasis in adults. Bryhali belongs to a drug class called corticosteroids. Note:...
Can-Fite receives FDA IND clearance for Phase IIb MASH treatment trial
Clinical Trials Arena via Yahoo Finance· 4 days agoIIa study, we are proud to develop a new potential treatment to address this disease.” In August...